**Star News, PharmaBlock (300725) replied to investors' concerns on the investor relations platform on December 26.
Investors:Does the medicine stone have biosynthesis technology?
PharmaBlock Board Secretary:Hello investors, the company has established a perfect service capability in the field of enzyme catalysis: the scale of the enzyme library continues to expand, and there are more than 500 kinds of standing enzymes, of which more than 100 kinds of self-made enzymes have been successfully applied to production projects above kilogramsThe semi-rational design and directed evolution platform of enzymes have been developed and established, which can be used to study the catalytic activity or selectivity of a variety of commonly used enzymes, especially the development and application of high-throughput screening mutation platform, which can greatly improve the efficiency of mutation and screening. In terms of enzyme production, high-density fermentation units of different scales such as 7L, 100L and 500L have been built to meet the fermentation needs of different scalesThe immobilization technology suitable for different enzymes was developed, which improved the stability of enzymes, reduced the difficulty of post-processing, and promoted the industrial application of enzymes. Based on the existing technology, the company will continue to expand and improve the biocatalysis platform to promote the development of green chemistry and green chemical technology. Thank you for your interest!
Investors:What is the number of shareholders of the company as of December 20**?
PharmaBlock Board Secretary:As of December 20, 2023, the number of shareholders of the company is: 29,856.
Investors:What is the number of shareholders of the company as of December 20**?
PharmaBlock Board Secretary:As of December 20, 2023, the number of shareholders of the company is: 29,856.
The above content is compiled by **Star based on public information, generated by algorithms, and has nothing to do with the position of this site. **Star strives but does not guarantee the accuracy, completeness, validity, timeliness of all or part of the content of the information (including but not limited to text, **audio, data and charts), if there is any problem, please contact us. This article is a compilation of data and does not constitute any investment advice for you, investment is risky, please make a cautious decision.